These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1488480)

  • 1. Post-mortem studies in affective disorder.
    Ferrier IN; Perry EK
    Psychol Med; 1992 Nov; 22(4):835-8. PubMed ID: 1488480
    [No Abstract]   [Full Text] [Related]  

  • 2. Colocalization of corticotropin-releasing hormone and oestrogen receptor-alpha in the paraventricular nucleus of the hypothalamus in mood disorders.
    Bao AM; Hestiantoro A; Van Someren EJ; Swaab DF; Zhou JN
    Brain; 2005 Jun; 128(Pt 6):1301-13. PubMed ID: 15705605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Listening to mutant mice: a spotlight on the role of CRF/CRF receptor systems in affective disorders.
    Keck ME; Ohl F; Holsboer F; Müller MB
    Neurosci Biobehav Rev; 2005; 29(4-5):867-89. PubMed ID: 15899517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRF system and mood disorders.
    Aubry JM
    J Chem Neuroanat; 2013 Dec; 54():20-4. PubMed ID: 24060608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological changes of the brain in mood disorders.
    Wilczyńska K; Simonienko K; Konarzewska B; Szajda SD; Waszkiewicz N
    Psychiatr Pol; 2018 Oct; 52(5):797-805. PubMed ID: 30584814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical and clinical studies with corticotropin-releasing factor: implications for affective disorders.
    Owens MJ; Nemeroff CB
    Psychopharmacol Bull; 1988; 24(3):355-9. PubMed ID: 3153493
    [No Abstract]   [Full Text] [Related]  

  • 7. Postmortem and cerebrospinal fluid studies of corticotropin-releasing factor in humans.
    Hartline KM; Owens MJ; Nemeroff CB
    Ann N Y Acad Sci; 1996 Mar; 780():96-105. PubMed ID: 8602742
    [No Abstract]   [Full Text] [Related]  

  • 8. Limbic-hypothalamic-pituitary-adrenal axis activity and ventricular-to-brain ratio studies in affective illness and schizophrenia.
    Risch SC; Lewine RJ; Kalin NH; Jewart RD; Risby ED; Caudle JM; Stipetic M; Turner J; Eccard MB; Pollard WE
    Neuropsychopharmacology; 1992 Feb; 6(2):95-100. PubMed ID: 1319168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders.
    Cecil KM; DelBello MP; Sellars MC; Strakowski SM
    J Child Adolesc Psychopharmacol; 2003; 13(4):545-55. PubMed ID: 14977467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affective temperamental profiles are associated with white matter hyperintensity and suicidal risk in patients with mood disorders.
    Serafini G; Pompili M; Innamorati M; Fusar-Poli P; Akiskal HS; Rihmer Z; Lester D; Romano A; de Oliveira IR; Strusi L; Ferracuti S; Girardi P; Tatarelli R
    J Affect Disord; 2011 Mar; 129(1-3):47-55. PubMed ID: 20708276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies.
    Heim C; Nemeroff CB
    Biol Psychiatry; 2001 Jun; 49(12):1023-39. PubMed ID: 11430844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal glucocorticoid programming of brain corticosteroid receptors and corticotrophin-releasing hormone: possible implications for behaviour.
    Welberg LA; Seckl JR; Holmes MC
    Neuroscience; 2001; 104(1):71-9. PubMed ID: 11311532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The involvement of retinoic acid receptor-alpha in corticotropin-releasing hormone gene expression and affective disorders.
    Chen XN; Meng QY; Bao AM; Swaab DF; Wang GH; Zhou JN
    Biol Psychiatry; 2009 Nov; 66(9):832-9. PubMed ID: 19596122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRH signaling. Molecular specificity for drug targeting in the CNS.
    Refojo D; Holsboer F
    Ann N Y Acad Sci; 2009 Oct; 1179():106-19. PubMed ID: 19906235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders.
    Ressler KJ; Nemeroff CB
    Depress Anxiety; 2000; 12 Suppl 1():2-19. PubMed ID: 11098410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volumetric analysis of septal region in schizophrenia and affective disorder.
    Brisch R; Bernstein HG; Krell D; Stauch R; Trübner K; Dobrowolny H; Kropf S; Bielau H; Bogerts B
    Eur Arch Psychiatry Clin Neurosci; 2007 Apr; 257(3):140-8. PubMed ID: 17180571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing aversive emotional states through the heart in mice: implications for cardiovascular dysregulation in affective disorders.
    Stiedl O; Jansen RF; Pieneman AW; Ogren SO; Meyer M
    Neurosci Biobehav Rev; 2009 Feb; 33(2):181-90. PubMed ID: 18824021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid sensitivity in mood disorders.
    Spijker AT; van Rossum EF
    Neuroendocrinology; 2012; 95(3):179-86. PubMed ID: 22076031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress and affective disorders: animal models elucidating the molecular basis of neuroendocrine-behavior interactions.
    Touma C
    Pharmacopsychiatry; 2011 May; 44 Suppl 1():S15-26. PubMed ID: 21544741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotransmitter receptor-mediated activation of G-proteins in brains of suicide victims with mood disorders: selective supersensitivity of alpha(2A)-adrenoceptors.
    González-Maeso J; Rodríguez-Puertas R; Meana JJ; García-Sevilla JA; Guimón J
    Mol Psychiatry; 2002; 7(7):755-67. PubMed ID: 12192620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.